Experience, Expertise, and Understanding – Building Critical Insight into Smart ICSRs
Individual Case Safety Reports, or ICSRs, are a large part ...
Navigating to Help Pharma During These Challenging Times – Meet Ashok Katti, COO & President APAC, ArisGlobal
As part of our executive series, the ArisGlobal marketing department recently spent ...
AI Enhanced RIMS: What the Future Holds for Regulatory
Christina Johnston, Associate Director of Product Management for Regulatory at ...
Best Practices for Digitally Transforming Pharmacovigilance Processes
On June 9th, 2020 ArisGlobal held a webinar titled “Pharmacovigilance and ...
Digitally Transforming Pharmacovigilance Processes Remains a Key Life Sciences Priority
On June 9, 2020 ArisGlobal held a webinar titled “Pharmacovigilance and Digital Transformation: Stepping into ...
ArisGlobal Presented “The Evolving Role of CTMS in Risk Management” at DIA 2020 Annual Meeting
On June 16th, 2020, ArisGlobal participated in the 2020 DIA ...
Is Regulatory Affairs Ready for Automation? Part 3: Rating Your Organization’s Regulatory Data Science Capabilities
As evident from our second polling question, ”How far along the road would you say you are for a ‘new’ technological revolution,” the journey to capitalize on the next industrial revolution is just beginning for most participants
Is Regulatory Affairs Ready for Automation? Part 2: Are you Ready for a ‘New’ Technological Revolution?
As evident from our second polling question, ”How far along the road would you say you are for a ‘new’ technological revolution,” the journey to capitalize on the next industrial revolution is just beginning for most participants
Is Regulatory Affairs Ready for Automation? Part 1: What Is Your Greatest Regulatory Challenge?
Automation technologies are having a major impact on performance and productivity across industries. In regulatory, these technologies also have the potential to reshape many activities across regulatory, leading to significant productivity gains. While there’s a lot of talk about how automation technologies will create new roles with exciting opportunities, the most powerful impact will be on the data quality and the efficiency with which manual tasks will be accomplished.
Mobility and Medical Affairs: Enabling Communication and Collaboration across the Stakeholder Spectrum – Part 1
“The most competitive pharma companies in the coming decade will be masters of data and digital technologies.” So begins the June 2017 industry brief, “Reinventing the Role of Medical Affairs,” by Bain & Company.
